Fundraising Fox

APOLLO PROJECTS2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Praxispraxismedicines.comin𝕏NASDAQ: PRAXMar 2022 · $15M

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.

BiotechDeep TechHealthtechBoston, US

Steve Petrou(Co-Founder, President of Research & Development)inKiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in

BoardNicholas G. Galakatos(Director)

Co-investorsAvoro Capital AdvisorsCapria VenturesOCV PartnersAlameda ResearchBlackstoneClarus+6 more

Marvinmeetmarvin.cominFeb 2022

Marvin provides mental health and well-being support for healthcare employees, combining input from therapists, academic researchers, data scientists, and clinical operations leaders.

AI & Machine LearningDigital HealthHealthtechMental HealthSan Marino, US

John Bracaglia(Executive Officer, Director)in

Co-investorsCanvas VenturesDesigner FundCanaan PartnersCanaryFuel CapitalGaingels+5 more

Mozart Datamozartdata.comin𝕏Apr 2022 · $15M

Mozart Data provides a data platform for centralizing, organizing, and analyzing business data without requiring engineering expertise.

Cloud ComputingData & InfrastructureEnterprise SoftwareSaaSSan Francisco, US

Peter Fishman(Founder)inDan Silberman(Founder)in

Co-investorsAbstract VenturesRackhouse Venture Management LpY CombinatorCraft VenturesGoldcrest CapitalSignia Venture Partners+1 more

Praxis Societypraxissociety.com𝕏Mar 2022 · $15M

Praxis is an online membership community aiming to build a new city described as a digital nation, organizing online events, projects, and eventual physical relocation for members.

Social

Co-investorsPronomos CapitalAlameda ResearchParadigmRobot VenturesUncommon

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.